Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression-Reference-Cited by-同舟云学术

Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

Published:2004-09-13 Issue:38 Volume:101 Page:13885-13890
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Oka Y.,Tsuboi A.,Taguchi T.,Osaki T.,Kyo T.,Nakajima H.,Elisseeva O. A.,Oji Y.,Kawakami M.,Ikegame K.,Hosen N.,Yoshihara S.,Wu F.,Fujiki F.,Murakami M.,Masuda T.,Nishida S.,Shirakata T.,Nakatsuka S.-i.,Sasaki A.,Udaka K.,Dohy H.,Aozasa K.,Noguchi S.,Kawase I.,Sugiyama H.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference43 articles.

1. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

2. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

3. Repression of the Insulin-Like Growth Factor II Gene by the Wilms Tumor Suppressor WT1

4. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis.

Cited by 471 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance Therapy in Acute Myeloid Leukemia;American Journal of Clinical Oncology;2024-09-06

2. Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia;Annals of Hematology;2024-08-29

3. iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens;Frontiers in Oncology;2024-08-26

4. Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations;Current Oncology;2024-08-23

5. Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective;Vaccines;2024-08-22